Validating claims-based definitions for deprescribing: Bridging the gap between clinical and administrative data.
Joshua D NiznikShahar ShmuelVirginia PateCarolyn T ThorpeLaura C HansonColleen RiceJennifer L LundPublished in: Pharmacoepidemiology and drug safety (2024)
The sensitivity of claims-based definitions for deprescribing of BZDs was low; however, the specificity of a 90-day gap was >90%. Replication in other EHRs and for other low-value medications is needed to guide future deprescribing research.